ATBC Compliance: Match Evidence to Each Market
ATBC Compliance: Match Evidence to Each Market
ATBC qualification is an end-use and jurisdiction question, not a single-certificate check. Acetyl Tributyl Citrate (ATBC), identified by CAS 77-90-7, has regulatory records and reported uses relevant to several markets, but a substance-level listing does not by itself authorize every formulation or finished article. Buyers should match each intended use to the applicable rule, substrate, conditions of use, and evidence for the actual product being purchased.
This distinction matters when comparing ATBC with conventional phthalates such as DBP, DOP, DINP, and DPHP, or with other non-phthalate plasticizers such as DOTP, ESO, TBC, and TEC. The supplied evidence supports identifying these as separate substances and product categories; it does not provide a complete, current regulatory comparison among them. A substitution decision therefore needs to be checked against the buyer’s target market and application rather than inferred from labels such as “non-phthalate,” “food-grade,” or “environment-friendly.”
Procurement takeaway: bind the purchase specification to the exact substance and CAS number, then verify the regulatory basis for the particular end use. Treat a supplier’s management-system certificate, a general SDS, and a food-contact or product-use authorization as different kinds of evidence.
Start with chemical identity, not a marketing or trade name
ATBC is also identified in authoritative records as tributyl acetylcitrate or tributyl O-acetylcitrate, CAS 77-90-7. The FDA inventory record identifies the substance by this CAS number, and an ECHA risk-management document uses the name tributyl O-acetylcitrate. NIST publishes an IR spectrum record for tributyl acetylcitrate. These references provide useful identity checks; they do not certify a supplier’s particular lot or establish that the material meets a buyer’s grade specification.
Identity discipline is especially important when sourcing citrate esters. ATBC is not the same substance as Tributyl citrate (TBC) or Triethyl citrate (TEC). A similar name, a shared citrate description, or an abbreviated product label is not enough to establish equivalence. In an RFQ, purchase order, certificate of analysis (CoA), and safety data sheet (SDS), specify “Acetyl Tributyl Citrate (ATBC), CAS 77-90-7.” Check that the documents refer to the same material and that the lot identification connects them to the shipment.
The ECHA RMOA reports ATBC’s molecular formula as C20H34O8 and molecular weight as 402.5 g/mol. NIST’s reference record reports the same formula and a relative molecular mass of 402.48. These are reference identity descriptors, not acceptance limits for purity or a substitute for lot testing. Where a buyer needs an incoming identity check, the NIST IR record can inform a method discussion with the quality team. The analytical method, reference material, acceptance decision, and laboratory responsibility still need to be agreed for the specific purchase.
What the regulatory records establish—and what they do not
For the United States, the supplied FDA evidence includes an FDA update dated October 29, 2024, reporting that 21 CFR 178.3740 permits ATBC as a plasticizer in polymers used in food-contact articles. The FDA inventory record for tributyl acetylcitrate also lists references to sections 172.515, 175.105, 175.300, 175.320, 178.3910, and 181.27. Those entries are useful starting points for regulatory review, not a blanket conclusion that any ATBC-containing product, concentration, polymer, food type, or use condition is authorized.
For a U.S. food-contact project, identify the intended article and polymer, the role and concentration of ATBC, and the applicable conditions of use. Then confirm the relevant current legal text and supporting documentation with the responsible regulatory or compliance reviewer. The FDA inventory’s listed sections should be read in their application context; their presence does not establish unrestricted approval across all food-contact uses. Nor should a general supplier statement be treated as a substitute for evidence linking the supplied grade and formulation to the proposed finished article.
For the European Union, ECHA provides a substance information entry for tributyl O-acetylcitrate, and its records describe use categories that include polymers, coatings, inks and toners, adhesives and sealants, pharmaceuticals, cosmetics, and leather-treatment products. ECHA’s substance information covers chemical properties, classification, and labelling. A reported use category is not a product authorization, food-contact approval, or proof of compliance for a particular finished article. The supplied evidence does not establish an ATBC-specific EU food-contact authorization entry or migration limit. Buyers should verify the applicable legal route for their exact product and use rather than treating an ECHA listing as the answer to that question.
For pharmaceutical applications in the United States, a 2018 indexed peer-reviewed publication describes ATBC as an FDA-approved substance for use as a pharmaceutical excipient. The exact CFR citation was not captured in the supplied evidence. This reported excipient context does not automatically extend to food packaging, toys, medical devices, or other uses. Buyers evaluating a pharmaceutical application should obtain the applicable regulatory citation and grade-specific documentation for the intended product.
For other destinations, including China and markets in Asia, the supplied material does not provide a complete jurisdiction-by-jurisdiction authorization matrix for ATBC. Do not infer local inventory status, food-contact permission, or finished-product compliance from a U.S. or EU reference. Establish the importing jurisdiction, the product category, and the relevant local rule before placing the material into a regulated formulation.
How to interpret supplier certificates
A management-system certificate can support supplier qualification, but it is not an ATBC product approval. The supplied records for SHANDONG KEXING GHEMICAL CO.,LTD include a quality management system certificate to GB/T 19001-2016 / ISO 9001:2015, certificate number 66725Q0037R0M, with an issue date of January 13, 2025, and an expiry date of January 12, 2028. Its stated scope covers production of plasticizers, oilfield additives, and modified water-treatment agents, as well as specified oilfield engineering technical services.
The supplied environmental management system record lists GB/T 24001-2016 / ISO 14001:2015, certificate number 66725E0038R0M, and the same issue and expiry dates. Its stated scope also concerns production and technical services. These records describe management systems and stated scopes; they do not establish that a specific ATBC grade meets a food-contact, toy, medical-device, or pharmaceutical requirement. The supplied HSE certificate, number 667240083R1S, has an expiry date of February 28, 2027. Buyers reviewing certificates should confirm the current certificate copy, issuer, scope, entity name, and validity directly as part of qualification.
SHANDONG KEXING GHEMICAL CO.,LTD’s supplied company profile describes the company as a manufacturer of plasticizers and other additives and lists ATBC, TBC, TEC, DOTP, ESO, DINP, DOP, DBP, and DPHP among its products. That portfolio information helps identify products for a sourcing discussion, but it does not mean that one certificate, specification, or regulatory claim applies to every product. Ask for documentation specific to ATBC and to the intended grade.
Comparing ATBC with phthalates and other alternatives
ATBC’s regulatory position should be compared with DBP, DOP, DINP, and DPHP only against the same market, end use, product form, and relevant legal requirements. The supplied evidence contains no current, jurisdiction-specific regulatory profiles for those four phthalates, so it cannot support a statement that ATBC is universally permitted where they are restricted, or that any one of them is approved or prohibited for a particular application. Those conclusions require current authoritative evidence for each substance and use.
The same limit applies to alternative non-phthalate materials. DOTP, ESO, TBC, and TEC are identified in the company’s supplied product portfolio, but portfolio presence is not proof of regulatory suitability or functional equivalence. The evidence does not establish comparative migration, plasticizing efficiency, compatibility, or application-specific test results among these materials. For a substitution review, compare each candidate’s identity, applicable market requirements, grade documentation, and test results under the buyer’s formulation and finished-product conditions.
One specific distinction in the supplied ECHA RMOA is a risk-screening classification: it reports ATBC as Cramer class III and TBC as Cramer class I in that assessment context. The same source cautions against treating this classification as a complete toxicological or regulatory approval conclusion. It does not demonstrate that ATBC is unsafe, that TBC is automatically preferable, or that either is approved for a particular use. It is a reason to keep the substances and the scope of the assessment distinct during regulatory review.
Match the evidence to the end market
| End-market question | Evidence to establish | What not to assume |
|---|---|---|
| Food-contact packaging or film | Target jurisdiction; polymer and article; intended conditions of use; applicable legal citation; documentation connecting the ATBC grade and formulation to the use. | A listed FDA reference or the phrase “food-grade ATBC” alone establishes compliance for every packaging application. |
| Pharmaceutical excipient | Applicable jurisdiction and excipient route; the exact regulatory citation; grade-specific identity and quality documentation. | A reported U.S. excipient context automatically covers medical devices or other regulated products. |
| Toys or children’s products | Target-market rules for the finished article, material composition, and any required application-specific test evidence. | “Non-phthalate” alone proves toy compliance or establishes safety for every age group and use. |
| Industrial polymers, inks, coatings, or leather treatment | Intended function and formulation; applicable chemical communication and market requirements; agreed product specification and batch evidence. | An ECHA-reported use category proves performance or authorization for a buyer’s exact formulation. |
This table is a qualification framework, not a jurisdictional legal opinion or a substitute for checking the current rules. Where the supplied sources establish only identity or reported use, treat that information as a screening input. For regulated finished goods, responsibility for demonstrating compliance depends on the applicable rule and the roles of the parties in the supply chain.
Purchase terms and acceptance criteria
Qualification becomes operational when the regulatory question is translated into contract documents and shipment acceptance rules. The supplied purchasing terms and acceptance criteria record specifies a minimum order quantity of 1 tonne, delivery terms of FOB or CIF, acceptance against a factory test report, and payment terms of 30% deposit with the remaining 70% payable upon receipt of the bill of lading. These are the stated terms in that content unit; buyers should confirm that each term appears in the actual quotation and contract for the order, including the applicable version and any agreed changes.
“Factory test report” should be made concrete before ordering. Define which lot or batch it covers, what identity and specification fields it must contain, who issues it, when it is provided, and how a discrepancy is handled. The supplied evidence does not provide a complete ATBC commercial specification table or tolerance limits for parameters such as purity, acid value, moisture, color, or migration. Do not invent thresholds. Instead, agree the required parameters and acceptance limits in the purchase specification, and require the supplier’s report to show the result, method where relevant, and lot reference.
Keep regulatory qualification separate from routine lot acceptance. A factory test report may help establish whether a shipment meets agreed technical criteria; it does not by itself demonstrate that the finished article complies with food-contact, toy, medical-device, or pharmaceutical requirements. Conversely, an external regulatory reference does not show that a delivered lot matches the purchase specification. Both questions need their own documented evidence and review.
Buyer due-diligence checklist
- Bind the identity. State Acetyl Tributyl Citrate (ATBC) and CAS 77-90-7 in the RFQ, specification, CoA, SDS, and purchase order. Check that TBC or TEC has not been substituted through an ambiguous name.
- Define the actual use. Record the destination market, product category, polymer or formulation, and intended conditions of use. “Food-grade,” “medical,” or “toy” is not a sufficient use description on its own.
- Verify the regulatory route. Identify the applicable current rule or official record for the precise use. Confirm the conditions and scope; do not extend one market’s evidence to another jurisdiction.
- Request product-specific documents. Review the current SDS, grade-specific technical data, lot-linked CoA or factory test report, and any relevant application or compliance statement. Check that documents identify the same substance and supplier entity.
- Check certificate scope. Confirm the certificate holder, issuer, standard, scope, validity, and current status. Do not describe a management-system certificate as product certification or end-use authorization.
- Agree acceptance and remedy terms. Specify test-report content, lot identification, acceptance criteria, document timing, and the contractual process for a non-conforming shipment. Confirm the stated MOQ, FOB or CIF basis, and payment schedule in the order documents.
- Separate substitution evidence. For DBP, DOP, DINP, DPHP, DOTP, ESO, TBC, or TEC comparisons, verify each substance’s identity, market rules, grade, and relevant test evidence independently. Do not infer equivalence from a shared function or product portfolio.
Conclusion: qualify the use, then qualify the lot
ATBC has identifiable regulatory and technical references, including U.S. food-contact references, ECHA substance information, and an ECHA-reported pharmaceutical-use assessment. Each supports a bounded conclusion, not universal approval. For buyers moving from evaluation to execution, the practical sequence is to define the destination and use, confirm the applicable regulatory basis, bind the identity to CAS 77-90-7, verify supplier and product documents separately, and turn the agreed technical and commercial conditions into written acceptance criteria.
That sequence also makes comparisons more defensible. ATBC should not be treated as automatically interchangeable with DBP, DOP, DINP, DPHP, DOTP, ESO, TBC, or TEC. Each candidate needs its own evidence for the intended market and formulation. A clear boundary between management-system certification, regulatory status, and lot-level conformity helps procurement teams avoid treating one document as proof of all three.
Frequently asked questions
Does an FDA listing mean ATBC is approved for every food-contact application?
No. The supplied FDA record reports a permission under 21 CFR 178.3740 and lists other regulatory references, but those references do not establish unrestricted approval for every concentration, substrate, food type, or condition of use. Buyers need to verify the current rule and its application to the specific article.
Does an ISO 9001 certificate certify ATBC as food-grade?
No. The supplied ISO 9001:2015 certificate covers a stated management-system scope that includes production of plasticizers and other activities. It is not an ATBC grade certificate or a food-contact authorization. Request product-specific and use-specific evidence separately.
What should an RFQ specify to avoid confusion between ATBC and TBC?
Use the full name Acetyl Tributyl Citrate (ATBC) and CAS 77-90-7. Apply the same identity wording to the RFQ, specification, CoA, SDS, and purchase order, and check that the shipment’s lot documents match it. TBC and ATBC are different substances.
Can ATBC be assumed to replace DBP, DOP, DINP, or DPHP in a regulated product?
No. The supplied evidence does not provide a complete regulatory comparison or comparative performance tests for these materials. Verify the rules for each substance in the destination market and assess the candidate formulation against the product’s requirements before treating a substitution as qualified.
What are the stated purchase and acceptance terms?
The supplied purchasing record states an MOQ of 1 tonne, FOB or CIF delivery terms, acceptance against a factory test report, and payment of 30% deposit with 70% due upon receipt of the bill of lading. Confirm the terms, report content, lot coverage, and acceptance criteria in the quotation and contract for the specific order.
¿Tiene preguntas o necesita más detalles?
Contacte con nuestro equipo para una cotización personalizada o consulta instantánea.
Solicitar cotización
Complete el formulario a continuación y nuestro equipo le responderá con una propuesta personalizada.
Chat directo de WhatsApp
¿Prefiere chatear en tiempo real? Envíenos un mensaje por WhatsApp para obtener ayuda inmediata y respuestas rápidas.
- Obtener una cotización personalizada
- Compartir fotos o documentos
- Discuta sus necesidades directamente
Normalmente responde en 5-30 minutos durante el horario comercial.
